The ability of CUG-BP and hnRNPM to diametrically regulate QKI-7 in diabetes consequently offers a potential therapeutic avenue to restore vascular health in such individuals, whether through indirectly correcting the balance of the splicing factors or directly targeting QKI-7 expression for example. The gene discussed is CELF1; the disease is diabetes mellitus.